Abiodun Oguntuga Ogundaini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Abiodun Oguntuga Ogundaini has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
Lars Bohlin
Division of Pharmacognosy, Uppsala University, Biomedical Centre, Box 579, S‐751 23, Uppsala, Sweden
4 shared publicationsFrancis O. Ogungbamila
3 shared publications- Thomas Oyebode Idowu
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria
3 shared publications Berhanu M. Abegaz
African Academy of Sciences, Nairobi, Kenya
2 shared publicationsEm Obuotor
Obafemi Awolowo Univ, Dept Biochem, Ife, Osun State, Nigeria
2 shared publications- Fidele Ntie-Kang
University of Buea
2 shared publications
Latest Publications
- 3 September 2020
- Published by Bentham Science Publishers Ltd. in Current Computer-Aided Drug Design
- Vol. 16 (4) , 376-388
Computational Prospecting for the Pharmacological Mechanism of Activity: HIV-1 Inhibition by Ixoratannin A-2
Background: Ixora coccinea is a tropical ornamental shrub employed in ethnomedicine for the treatment of a number of diseases none of which include the Human Immunodeficiency Virus (HIV) infection. Ixoratannin A-2, one of the constituents, was previously identified via virtual-screening and experimentally confirmed to possess significant anti-HIV-1 activity in an in vitro CD4+ replication assay. This activity was observed to be significantly reduced in degree in viruses lacking the protein Vpu. This suggests the involvement of Vpu as well as other extra-Vpu macromolecules in its antiviral activity.Methods: In the present computational search for the identity of the other macromolecules that could possibly explain the observed activity, a panel of fourteen established HIV-1 macromolecular targets was assembled against which ixoratannin A-2 and other major phytoconstituents of I. coccinea were virtually screened.Results: Structural analyses of the computed ligand-bound complexes, as well as the careful investigation of the thermodynamic attributes of the predicted binding, revealed subtle selectivity patterns at the atomistic level that suggest the likely involvement of multiple macromolecular processes. Some of the binding interactions were found to be thermodynamically favourable, including the multidrug-resistant HIV protease enzyme, CXCR4 and the human elongin C protein all of which formed reasonably strong interactions with ixoratannin A-2 and other constituents of I. coccinea.Conclusion: Ixoratannin A-2’s ability to favourably interact with multiple HIV-1 and human targets could explain its observed extra-Vpu antiviral activity. This, however, does not imply uncontrolled binding with all available targets; on the other hand, molecular size of ixoratannin A-2 and combination of functional groups confer on it a decent level of selectivity against many of the investigated HIV/AIDS targets.
- 3 September 2020
- Published by Bentham Science Publishers Ltd. in Current Computer-Aided Drug Design
- Vol. 16 (4) , 376-388
Computational Prospecting for the Pharmacological Mechanism of Activity: HIV-1 Inhibition by Ixoratannin A-2
Background: Ixora coccinea is a tropical ornamental shrub employed in ethnomedicine for the treatment of a number of diseases none of which include the Human Immunodeficiency Virus (HIV) infection. Ixoratannin A-2, one of the constituents, was previously identified via virtual-screening and experimentally confirmed to possess significant anti-HIV-1 activity in an in vitro CD4+ replication assay. This activity was observed to be significantly reduced in degree in viruses lacking the protein Vpu. This suggests the involvement of Vpu as well as other extra-Vpu macromolecules in its antiviral activity.Methods: In the present computational search for the identity of the other macromolecules that could possibly explain the observed activity, a panel of fourteen established HIV-1 macromolecular targets was assembled against which ixoratannin A-2 and other major phytoconstituents of I. coccinea were virtually screened.Results: Structural analyses of the computed ligand-bound complexes, as well as the careful investigation of the thermodynamic attributes of the predicted binding, revealed subtle selectivity patterns at the atomistic level that suggest the likely involvement of multiple macromolecular processes. Some of the binding interactions were found to be thermodynamically favourable, including the multidrug-resistant HIV protease enzyme, CXCR4 and the human elongin C protein all of which formed reasonably strong interactions with ixoratannin A-2 and other constituents of I. coccinea.Conclusion: Ixoratannin A-2’s ability to favourably interact with multiple HIV-1 and human targets could explain its observed extra-Vpu antiviral activity. This, however, does not imply uncontrolled binding with all available targets; on the other hand, molecular size of ixoratannin A-2 and combination of functional groups confer on it a decent level of selectivity against many of the investigated HIV/AIDS targets.
- 6 November 2015
- Published by African Journals Online (AJOL) in African Journal of Traditional, Complementary and Alternative Medicines
- Vol. 12 (6) , 140-144
Radical scavenging compounds from the aerial parts of Solenostemon monostachys briq (Lamiaceae)
Background: Solenostemon monostachys Briq. (Lamiaceae) is a weed widely used in ethno medicine to treat infections and inflammatory conditions but the active compounds are yet to be identified. This study isolated and identified the radical scavenging compounds from S. monostachys crude extract using diphenyl-1, 1-picryl hydrazyl (DPPH) to monitor the separation. Materials and Methods: The crude extract of the aerial parts of the plant was evaluated for antimicrobial activity using the agar diffusion test, anti-inflammatory test using carrageenan induced oedema of the rat paw and radical scavenging test using diphenyl-1, 1-picryl hydrazyl (DPPH). Repeated chromatographic separation of the ethyl acetate and n-butanol fractions on silica gel and Sephadex LH-20, monitored by DPPH bio-autographic assay resulted in the isolation of seven active compounds, which were identified using spectroscopic methods and comparison with literature data. Results: The ethyl acetate and n-butanol fractions were the most active fractions and contained apigenin, apigenin glucuronide, luteolin, caffeic acid, methyl caffeate, rosmarinic acid and methyl rosmarinate as the radical scavenging compounds with EC50 values of 26.67 ± 0.31, 185.89 ± 1.02, 5.35 ± 0.31, 3.92 ± 0.06, 13.41 ± 0.18, 4.99 ± 0.10, 5.97 ± 0.08 μg/ml respectively compared with 2.32 ± 0.08 μg/ml for quercetin as the reference standard. Conclusion: The isolated compounds are reported for the first time in this plant. The presence of the compounds in S. monostachys P. Beauv. (Briq.) (Lamiaceae) may provide justification for some of the ethnomedicinal uses of the plant in infections and inflammatory conditions. Keywords: Flavonoids, caffeic acid derivatives, radical scavenging ability, Lamiaceae
- 6 November 2015
- Published by African Journals Online (AJOL) in African Journal of Traditional, Complementary and Alternative Medicines
- Vol. 12 (6) , 140-144
Radical scavenging compounds from the aerial parts of Solenostemon monostachys briq (Lamiaceae)
Background: Solenostemon monostachys Briq. (Lamiaceae) is a weed widely used in ethno medicine to treat infections and inflammatory conditions but the active compounds are yet to be identified. This study isolated and identified the radical scavenging compounds from S. monostachys crude extract using diphenyl-1, 1-picryl hydrazyl (DPPH) to monitor the separation. Materials and Methods: The crude extract of the aerial parts of the plant was evaluated for antimicrobial activity using the agar diffusion test, anti-inflammatory test using carrageenan induced oedema of the rat paw and radical scavenging test using diphenyl-1, 1-picryl hydrazyl (DPPH). Repeated chromatographic separation of the ethyl acetate and n-butanol fractions on silica gel and Sephadex LH-20, monitored by DPPH bio-autographic assay resulted in the isolation of seven active compounds, which were identified using spectroscopic methods and comparison with literature data. Results: The ethyl acetate and n-butanol fractions were the most active fractions and contained apigenin, apigenin glucuronide, luteolin, caffeic acid, methyl caffeate, rosmarinic acid and methyl rosmarinate as the radical scavenging compounds with EC50 values of 26.67 ± 0.31, 185.89 ± 1.02, 5.35 ± 0.31, 3.92 ± 0.06, 13.41 ± 0.18, 4.99 ± 0.10, 5.97 ± 0.08 μg/ml respectively compared with 2.32 ± 0.08 μg/ml for quercetin as the reference standard. Conclusion: The isolated compounds are reported for the first time in this plant. The presence of the compounds in S. monostachys P. Beauv. (Briq.) (Lamiaceae) may provide justification for some of the ethnomedicinal uses of the plant in infections and inflammatory conditions. Keywords: Flavonoids, caffeic acid derivatives, radical scavenging ability, Lamiaceae
- Open Access
- 1 April 2015
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (4) , e0121099
Screening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors
The continued burden of HIV in resource-limited regions such as parts of sub-Saharan Africa, combined with adverse effects and potential risks of resistance to existing antiretroviral therapies, emphasize the need to identify new HIV inhibitors. Here we performed a virtual screen of molecules from the pan-African Natural Product Library, the largest collection of medicinal plant-derived pure compounds on the African continent. We identified eight molecules with structural similarity to reported interactors of Vpu, an HIV-1 accessory protein with reported ion channel activity. Using in vitro HIV-1 replication assays with a CD4+ T cell line and peripheral blood mononuclear cells, we confirmed antiviral activity and minimal cytotoxicity for two compounds, ixoratannin A-2 and boldine. Notably, ixoratannin A-2 retained inhibitory activity against recombinant HIV-1 strains encoding patient-derived mutations that confer resistance to protease, non-nucleoside reverse transcriptase, or integrase inhibitors. Moreover, ixoratannin A-2 was less effective at inhibiting replication of HIV-1 lacking Vpu, supporting this protein as a possible direct or indirect target. In contrast, boldine was less effective against a protease inhibitor-resistant HIV-1 strain. Both ixoratannin A-2 and boldine also inhibited in vitro replication of hepatitis C virus (HCV). However, BIT-225, a previously-reported Vpu inhibitor, demonstrated antiviral activity but also cytotoxicity in HIV-1 and HCV replication assays. Our work identifies pure compounds derived from African plants with potential novel activities against viruses that disproportionately afflict resource-limited regions of the world.
- 1 April 2015
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (4) , e0121099
Open AccessScreening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors
The continued burden of HIV in resource-limited regions such as parts of sub-Saharan Africa, combined with adverse effects and potential risks of resistance to existing antiretroviral therapies, emphasize the need to identify new HIV inhibitors. Here we performed a virtual screen of molecules from the pan-African Natural Product Library, the largest collection of medicinal plant-derived pure compounds on the African continent. We identified eight molecules with structural similarity to reported interactors of Vpu, an HIV-1 accessory protein with reported ion channel activity. Using in vitro HIV-1 replication assays with a CD4+ T cell line and peripheral blood mononuclear cells, we confirmed antiviral activity and minimal cytotoxicity for two compounds, ixoratannin A-2 and boldine. Notably, ixoratannin A-2 retained inhibitory activity against recombinant HIV-1 strains encoding patient-derived mutations that confer resistance to protease, non-nucleoside reverse transcriptase, or integrase inhibitors. Moreover, ixoratannin A-2 was less effective at inhibiting replication of HIV-1 lacking Vpu, supporting this protein as a possible direct or indirect target. In contrast, boldine was less effective against a protease inhibitor-resistant HIV-1 strain. Both ixoratannin A-2 and boldine also inhibited in vitro replication of hepatitis C virus (HCV). However, BIT-225, a previously-reported Vpu inhibitor, demonstrated antiviral activity but also cytotoxicity in HIV-1 and HCV replication assays. Our work identifies pure compounds derived from African plants with potential novel activities against viruses that disproportionately afflict resource-limited regions of the world.
- Open Access
- 5 March 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (3) , e90655
Virtualizing the p-ANAPL Library: A Step towards Drug Discovery from African Medicinal Plants
Natural products play a key role in drug discovery programs, both serving as drugs and as templates for the synthesis of drugs, even though the quantities and availabilities of samples for screening are often limitted. A current collection of physical samples of > 500 compound derived from African medicinal plants aimed at screening for drug discovery has been made by donations from several researchers from across the continent to be directly available for drug discovery programs. A virtual library of 3D structures of compounds has been generated and Lipinski’s “Rule of Five” has been used to evaluate likely oral availability of the samples. A majority of the compound samples are made of flavonoids and about two thirds (2/3) are compliant to the “Rule of Five”. The pharmacological profiles of thirty six (36) selected compounds in the collection have been discussed. The p-ANAPL library is the largest physical collection of natural products derived from African medicinal plants directly available for screening purposes. The virtual library is also available and could be employed in virtual screening campaigns.
- 5 March 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (3) , e90655
Open AccessVirtualizing the p-ANAPL Library: A Step towards Drug Discovery from African Medicinal Plants
Natural products play a key role in drug discovery programs, both serving as drugs and as templates for the synthesis of drugs, even though the quantities and availabilities of samples for screening are often limitted. A current collection of physical samples of > 500 compound derived from African medicinal plants aimed at screening for drug discovery has been made by donations from several researchers from across the continent to be directly available for drug discovery programs. A virtual library of 3D structures of compounds has been generated and Lipinski’s “Rule of Five” has been used to evaluate likely oral availability of the samples. A majority of the compound samples are made of flavonoids and about two thirds (2/3) are compliant to the “Rule of Five”. The pharmacological profiles of thirty six (36) selected compounds in the collection have been discussed. The p-ANAPL library is the largest physical collection of natural products derived from African medicinal plants directly available for screening purposes. The virtual library is also available and could be employed in virtual screening campaigns.
- 1 December 2010
- Published by Elsevier in Phytochemistry
- Vol. 71 (17-18) , 2092-2098
Doubly linked, A-type proanthocyanidin trimer and other constituents of Ixora coccinea leaves and their antioxidant and antibacterial properties
- 1 December 2010
- Published by Elsevier in Phytochemistry
- Vol. 71 (17-18) , 2092-2098
Doubly linked, A-type proanthocyanidin trimer and other constituents of Ixora coccinea leaves and their antioxidant and antibacterial properties
- 21 July 2009
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 75 (09) , PE25
Antioxidant compounds from Solenostemon monostachys (P.Beauv.) Briq. (Lamiaceae)
Solenostemon monostachys (P.Beauv.) Briq. (Lamiaceae) is used in ethnomedicine to treat convulsion, epilepsy, infection, rheumatism and other inflammatory conditions [1]. The crude 50% aqueous ethanolic extract of the aerial parts of the plant gave an inhibition of 68.8% in the carrageenan induced oedema of the rat paw test as against 81.3% by Indomethacin. Repeated chromatographic separation of the crude 50% aqueous ethanolic extract on silica gel and Sephadex LH-20 monitored by DPPH bioautographic assay led to the isolation of three compounds whose structure were determined using 1H NMR, 13C NMR (1D, 2D, APT) spectroscopy and comparison with literature values. The compounds were identified as caffeic acid (CA), rosmarinic acid, (RA) and methyl rosmarinate (MR). These compounds are reported for the first time in this plant. The Ferric Reducing Antioxidant Power assay gave 19.180, 5.740 and 9.730 mMol Fe2+/mg of RA, CA, and MR respectively against 4.40 and 7.90 mMol Fe2+/mg of BHT and Vit. C respectively. In the radical scavenging assay of the compounds using DPPH, the IC50 for the compounds were 43.3, 51.34 and 56.2µg/L for RA, MR and CA respectively against 61.45µg/L for gallic acid. Since reactive oxygen species are linked with inflammation, the presence of these compounds in Solenostemon monostachys P.Beauv. (Briq.) (Lamiaceae) may justify some of the ethnomedicinal uses of the plant. Acknowledgement: Central Science Laboratory, Obafemi Awolowo University, Ile Ife, Nigeria for the acquisition of the U.V and NMR spectra data. References: [1] Burkill, H.M. (1995) The useful plants of West Tropical Africa, 2nd Edition, Vol.3 Families J-L. Royal Botanical Gardens, Kew. United Kingdom.
- 21 July 2009
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 75 (09) , PE25
Antioxidant compounds from Solenostemon monostachys (P.Beauv.) Briq. (Lamiaceae)
Solenostemon monostachys (P.Beauv.) Briq. (Lamiaceae) is used in ethnomedicine to treat convulsion, epilepsy, infection, rheumatism and other inflammatory conditions [1]. The crude 50% aqueous ethanolic extract of the aerial parts of the plant gave an inhibition of 68.8% in the carrageenan induced oedema of the rat paw test as against 81.3% by Indomethacin. Repeated chromatographic separation of the crude 50% aqueous ethanolic extract on silica gel and Sephadex LH-20 monitored by DPPH bioautographic assay led to the isolation of three compounds whose structure were determined using 1H NMR, 13C NMR (1D, 2D, APT) spectroscopy and comparison with literature values. The compounds were identified as caffeic acid (CA), rosmarinic acid, (RA) and methyl rosmarinate (MR). These compounds are reported for the first time in this plant. The Ferric Reducing Antioxidant Power assay gave 19.180, 5.740 and 9.730 mMol Fe2+/mg of RA, CA, and MR respectively against 4.40 and 7.90 mMol Fe2+/mg of BHT and Vit. C respectively. In the radical scavenging assay of the compounds using DPPH, the IC50 for the compounds were 43.3, 51.34 and 56.2µg/L for RA, MR and CA respectively against 61.45µg/L for gallic acid. Since reactive oxygen species are linked with inflammation, the presence of these compounds in Solenostemon monostachys P.Beauv. (Briq.) (Lamiaceae) may justify some of the ethnomedicinal uses of the plant. Acknowledgement: Central Science Laboratory, Obafemi Awolowo University, Ile Ife, Nigeria for the acquisition of the U.V and NMR spectra data. References: [1] Burkill, H.M. (1995) The useful plants of West Tropical Africa, 2nd Edition, Vol.3 Families J-L. Royal Botanical Gardens, Kew. United Kingdom.
- Open Access
- 3 July 2006
- Published by African Journals Online (AJOL) in African Journal of Biomedical Research
- Vol. 8 (3) , 157-162
Mycelial growth and antibacterial metabolite production by wild mushrooms
Russula sp. and Pycnoporus cinnabarinus (wild mushrooms) were subjected to laboratory cultivation by spore germination and tissue culturing on Sabouraud dextrose agar plates. Subsequently, the growth and production of metabolite(s) were monitored in submerged fermentation for 7days using agar diffusion method. The result obtained showed that metabolite production peaked on the fourth day in Russula sp. and on the fifth day in Pycnoporus cinnabarinus with subsequent decrease in activity of the fermentation extract. Dry weight increases with fermentation time in both mushrooms. Keywords: wild mushroom, spore germination, tissue culturing, antibacterial metabolite African Journal of Biomedical Research Vol. 8(3) 2005: 157-162
- 3 July 2006
- Published by African Journals Online (AJOL) in African Journal of Biomedical Research
- Vol. 8 (3) , 157-162
Open AccessMycelial growth and antibacterial metabolite production by wild mushrooms
Russula sp. and Pycnoporus cinnabarinus (wild mushrooms) were subjected to laboratory cultivation by spore germination and tissue culturing on Sabouraud dextrose agar plates. Subsequently, the growth and production of metabolite(s) were monitored in submerged fermentation for 7days using agar diffusion method. The result obtained showed that metabolite production peaked on the fourth day in Russula sp. and on the fifth day in Pycnoporus cinnabarinus with subsequent decrease in activity of the fermentation extract. Dry weight increases with fermentation time in both mushrooms. Keywords: wild mushroom, spore germination, tissue culturing, antibacterial metabolite African Journal of Biomedical Research Vol. 8(3) 2005: 157-162
- 1 May 2003
- Published by Wiley in Phytotherapy Research
- Vol. 17 (5) , 555-557
Clinical evaluation of Acalypha ointment in the treatment of superficial fungal skin diseases
In an open non‐comparative study to evaluate the efficacy and safety of Acalypha wilkesiana ointment in superficial fungal skin diseases, 32 Nigerian patients with clinical and mycological evidence of superficial mycoses were recruited. Twelve patients defaulted and were lost to follow up, while one patient withdrew because of intolerable excoriation at the site of the lesion. Of the 19 patients that completed the trial, clinical cure was achieved in 73.3% of the patients. The ointment was very efficacious in the treatment of Tinea pedis, Pityriasis versicolor and Candida intetrigo where the cure rate was 100% in each condition. It is recommended that Acalypha ointment can be used for the treatment of these superficial mycoses. Copyright © 2003 John Wiley & Sons, Ltd.
- 1 May 2003
- Published by Wiley in Phytotherapy Research
- Vol. 17 (5) , 555-557
Clinical evaluation of Acalypha ointment in the treatment of superficial fungal skin diseases
In an open non‐comparative study to evaluate the efficacy and safety of Acalypha wilkesiana ointment in superficial fungal skin diseases, 32 Nigerian patients with clinical and mycological evidence of superficial mycoses were recruited. Twelve patients defaulted and were lost to follow up, while one patient withdrew because of intolerable excoriation at the site of the lesion. Of the 19 patients that completed the trial, clinical cure was achieved in 73.3% of the patients. The ointment was very efficacious in the treatment of Tinea pedis, Pityriasis versicolor and Candida intetrigo where the cure rate was 100% in each condition. It is recommended that Acalypha ointment can be used for the treatment of these superficial mycoses. Copyright © 2003 John Wiley & Sons, Ltd.
- Open Access
- 1 January 2003
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 26 (12) , 1674-1680
Hypotensive Activity of the Ethanol Extract of Pavetta crassipes Leaves
Pavetta crassipes leaf is routinely used locally in Nigeria for the management of respiratory disorders and hypertension. The hypotensive and other cardiovascular effects of Pavetta crassipes were investigated in cats and rats. The effects of the extract on rat and cat blood pressures, isolated rat atria, rat portal vein, isolated rat aorta and rat vas deferens were studied. Specific receptor antagonists (atropine, mepyramine, phentolamine, propranolol) were used to elucidate the underlying mechanism(s) involved in the cardiovascular changes induced by P. crassipes. The results revealed that the ethanolic extract of Pavetta crassipes lowered the blood pressures of cats and rats in a dose dependent manner. The extract also caused a concentration-dependent decrease in the force of contraction of the isolated rat atria and rat portal vein. The decreases in blood pressure values were attenuated in the presence of a β-adrenoceptor antagonist, propranolol. The extract also attenuated isoprenaline-induced contraction of the rat atria. However, the extract did not affect contractions evoked by KCl, norepinephrine and 5-HT on the rat aorta. Pavetta crassipes contains biologically active substances that may be useful in the management of hypertension.
- 1 January 2003
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 26 (12) , 1674-1680
Open AccessHypotensive Activity of the Ethanol Extract of Pavetta crassipes Leaves
Pavetta crassipes leaf is routinely used locally in Nigeria for the management of respiratory disorders and hypertension. The hypotensive and other cardiovascular effects of Pavetta crassipes were investigated in cats and rats. The effects of the extract on rat and cat blood pressures, isolated rat atria, rat portal vein, isolated rat aorta and rat vas deferens were studied. Specific receptor antagonists (atropine, mepyramine, phentolamine, propranolol) were used to elucidate the underlying mechanism(s) involved in the cardiovascular changes induced by P. crassipes. The results revealed that the ethanolic extract of Pavetta crassipes lowered the blood pressures of cats and rats in a dose dependent manner. The extract also caused a concentration-dependent decrease in the force of contraction of the isolated rat atria and rat portal vein. The decreases in blood pressure values were attenuated in the presence of a β-adrenoceptor antagonist, propranolol. The extract also attenuated isoprenaline-induced contraction of the rat atria. However, the extract did not affect contractions evoked by KCl, norepinephrine and 5-HT on the rat aorta. Pavetta crassipes contains biologically active substances that may be useful in the management of hypertension.
- 15 April 2000
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 63 (5) , 716-719
Petersaponins III and IV, Triterpenoid Saponins from Petersianthus macrocarpus
Two new triterpenoid saponins, petersaponins III and IV (1 and 2), were isolated from an n-butanol extract of the bark of Petersianthus macrocarpus. They possess 21-O-benzoyl-22-O-acetylbarringtogenol C and 21-O-2-furoxyl-22-O-tigloylbarringtogenol C as the aglycon, respectively. For both 1 and 2, the trisaccharide moiety linked to C-3 of the aglycon consists of d-glucuronic acid, d-xylose, and d-galactose, while a l-rhamnose unit is linked to C-28. The structures of 1 and 2 were elucidated by extensive NMR experiments including 1H−1H (COSY, HOHAHA, NOESY) and 1H−13C (HMQC and HMBC) spectroscopy and by chemical evidence.
- 15 April 2000
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 63 (5) , 716-719
Petersaponins III and IV, Triterpenoid Saponins from Petersianthus macrocarpus
Two new triterpenoid saponins, petersaponins III and IV (1 and 2), were isolated from an n-butanol extract of the bark of Petersianthus macrocarpus. They possess 21-O-benzoyl-22-O-acetylbarringtogenol C and 21-O-2-furoxyl-22-O-tigloylbarringtogenol C as the aglycon, respectively. For both 1 and 2, the trisaccharide moiety linked to C-3 of the aglycon consists of d-glucuronic acid, d-xylose, and d-galactose, while a l-rhamnose unit is linked to C-28. The structures of 1 and 2 were elucidated by extensive NMR experiments including 1H−1H (COSY, HOHAHA, NOESY) and 1H−13C (HMQC and HMBC) spectroscopy and by chemical evidence.